Exploring Women’s Leadership Equity in Anesthesiology: Trends Among Principal Investigators in Clinical Trials
Nicolas Mario Mas D Alessandro, MD; Faria Nisar, MD; Amir H. Karimi, BS; Samantha Pope, BS; Luis E. Tollinche, MD, FASA
MetroHealth Medical Center affiliated with
Case Western Reserve University School of Medicine, Cleveland, Ohio
Introduction & Background
•Despite growing numbers of women among medical students and physicians, they remain significantly underrepresented in leadership roles in anesthesiology.
•
•Current statistics reveal that only 18% of hospital CEOs, 16% of department chairs, and 7% of editors-in-chief are women.
•
•Study Objective
•Investigate gender representation among principal investigators (PIs) in anesthesiology clinical trials.
•Assess the extent of gender disparity and explore its implications for the field.
•Implications
•Understanding these disparities can inform strategies to promote gender equity in leadership within anesthesiology.
•Potential to drive systemic change by highlighting areas where interventions are needed.
MEthods
•Data from ClinicalTrials.gov (2007–2022) were analyzed to examine anesthesiology trials.
•
•PI gender was identified using Genderize.io.
•
•Key trial features analyzed included phase, funding source, and geographic distribution.
•
•Trends in female PI representation, trial characteristics, and regional differences were assessed.
Results
Discussion and Conclusion
•The proportion of female PIs in anesthesiology trials has grown over time, yet overall representation remains low.
•Differences in trial characteristics and geographic distribution highlight ongoing inequalities.
•Targeted interventions and policies are needed to promote inclusivity and diversity in research leadership.
•Continuous monitoring and evaluation of gender equity strategies are crucial to ensuring progress in anesthesiology clinical trial leadership.